Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Biomea Fusion, Inc. (BMEA)

0.6395 +0.0167 (+2.68%)
At close: October 30 at 4:00:01 PM EDT
0.6490 +0.0095 (+1.49%)
After hours: October 30 at 7:39:13 PM EDT
Chart Range Bar
Loading chart for BMEA
  • Previous Close 0.6228
  • Open 0.6300
  • Bid 0.6050 x 100
  • Ask 0.6393 x 100
  • Day's Range 0.5901 - 0.6489
  • 52 Week Range 0.5520 - 2.2370
  • Volume 1,097,038
  • Avg. Volume 2,125,751
  • Market Cap (intraday) 46.353M
  • Beta (5Y Monthly) -0.30
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2900
  • Earnings Date (est.) Nov 3, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 6.17
  • Zacks Rating Neutral

Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It's lead clinical program's drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical trials of icovamenib for the treatment of Type 1 and Type 2 diabetes; COVALENT-211, which is in Phase II clinical trial of icovamenib for treating insulin-deficient type 2 diabetes; and COVALENT-212, which is in Phase II clinical trial of icovamenib for the treatment of type 2 diabetes. The company is also developing BMF-650, which is in Phase I glucagon-like peptide-131 clinical trial for the treatment of obesity. The company was incorporated in 2017 and is headquartered in San Carlos, California.

biomeafusion.com

37

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BMEA
48.43%
S&P 500 (^GSPC)
10.73%

1-Year Return

BMEA
51.92%
S&P 500 (^GSPC)
11.11%

3-Year Return

BMEA
94.22%
S&P 500 (^GSPC)
81.91%

5-Year Return

BMEA
94.05%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue --
Earnings -8.33M
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-15M
-10M
-5M
0
0.0%

Analyst Insights

View More

Analyst Price Targets

4.00
6.17 Average
0.6395 Current
10.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/14/2026
Analyst Citizens
Rating Action Reiterates
Rating Market Outperform
Price Action Maintains
Price Target 7 -> 7

Statistics

View More

Valuation Measures

Annual
As of 10/30/2026
  • Market Cap

    46.35M

  • Enterprise Value

    12.41M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    3.82

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -63.46%

  • Return on Equity (ttm)

    -164.14%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -32.54M

  • Diluted EPS (ttm)

    -0.2900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    34.82M

  • Total Debt/Equity (mrq)

    7.23%

  • Levered Free Cash Flow (ttm)

    -27.8M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

0.6395 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 10/02/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 06/05/2023

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 05/18/2023

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 04/27/2023

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: